3-iodobenzylguanidine has been researched along with Depressive Disorder, Major in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kaneko, K; Matsumura, H; Nakagome, K; Ohta, Y; Pu, S; Terachi, S; Yamada, T; Yamanashi, T; Yokoyama, K | 1 |
Arai, T; Asada, T; Darby, D; Hattori, S; Kikuchi, N; Mizukami, K; Ogawa, R; Takahashi, S | 1 |
2 other study(ies) available for 3-iodobenzylguanidine and Depressive Disorder, Major
Article | Year |
---|---|
Milnacipran influences the indexes of I-metaiodobenzylguanidine scintigraphy in elderly depressed patients.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Antidepressive Agents; Brain; Cyclopropanes; Depressive Disorder, Major; Diagnosis, Differential; Female; Humans; Lewy Body Disease; Male; Milnacipran; Radionuclide Imaging; Radiopharmaceuticals | 2014 |
Ventilatory Response to Hypercapnia Predicts Dementia with Lewy Bodies in Late-Onset Major Depressive Disorder.
Topics: 3-Iodobenzylguanidine; Aged; Aged, 80 and over; Depressive Disorder, Major; Follow-Up Studies; Heart Rate; Humans; Hypercapnia; Hypotension, Orthostatic; Kaplan-Meier Estimate; Lewy Body Disease; Middle Aged; Partial Pressure; Psychiatric Status Rating Scales; Retrospective Studies; Ventilators, Mechanical | 2016 |